Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Inventory (2016 - 2025)

Rockwell Medical's Change in Inventory history spans 16 years, with the latest figure at -$904000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 90500.0% year-over-year to -$904000.0; the TTM value through Dec 2025 reached -$2.8 million, down 937.05%, while the annual FY2025 figure was -$2.8 million, 937.05% down from the prior year.
  • Change in Inventory reached -$904000.0 in Q4 2025 per RMTI's latest filing, down from -$257000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.5 million in Q1 2022 to a low of -$1.6 million in Q3 2023.
  • Average Change in Inventory over 5 years is -$43300.0, with a median of -$70500.0 recorded in 2022.
  • Peak YoY movement for Change in Inventory: skyrocketed 1056.86% in 2022, then crashed 90500.0% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $102000.0 in 2021, then surged by 1056.86% to $1.2 million in 2022, then plummeted by 67.37% to $385000.0 in 2023, then crashed by 99.74% to $1000.0 in 2024, then plummeted by 90500.0% to -$904000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Change in Inventory are -$904000.0 (Q4 2025), -$257000.0 (Q3 2025), and -$885000.0 (Q2 2025).